Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1998
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056913A1 Smad6 and uses thereof
12/17/1998WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998WO1998056910A1 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056812A2 Estrogen receptor crystals and ligands
12/17/1998WO1998056425A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056417A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998WO1998056409A1 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS
12/17/1998WO1998056408A2 Inhibitors of microbial adherence or invasion as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056407A2 Fibronectin antagonists as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
12/17/1998WO1998056404A1 Cns neuroregenerative compositions and methods of use
12/17/1998WO1998056378A1 Novel niddm regimen
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056365A1 COMPOSITIONS FOR TREATING AND PREVENTING ARTERIAL THROMBOSIS AND USE OF A FACTOR Xa INHIBITOR ON ITS OWN AND/OR COMBINED WITH A PLATELET ANTIAGGREGATING AGENT
12/17/1998WO1998056361A1 Drug targeting system, method of its preparation and its use
12/17/1998WO1998056360A2 Film-coated tablet for improved upper gastrointestinal tract safety
12/17/1998WO1998056356A1 Therapeutically active compositions
12/17/1998WO1998056346A1 Therapeutic or hygienic compositions with controlled and prolonged release of the active principle(s), in particular for ophthalmic use
12/17/1998WO1998056325A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998WO1998056323A1 Device and method for treatment of dysmenorrhea
12/17/1998WO1998056248A1 A novel method of detecting and treating cancer
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2295176A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
12/17/1998CA2293700A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998CA2293492A1 Cns neuroregenerative compositions and methods of use
12/17/1998CA2293439A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998CA2293350A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
12/17/1998CA2293302A1 Use of factor xiiia inhibitors to treat atherosclerosis
12/17/1998CA2293250A1 Human phosphatidylinositol transfer protein gamma
12/17/1998CA2293248A1 Human protein phosphatase ii-c-like protein
12/17/1998CA2292611A1 Estrogen receptor ligands
12/17/1998CA2292339A1 Smad6 and uses thereof
12/17/1998CA2291653A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
12/17/1998CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses
12/17/1998CA2289471A1 A novel method of detecting and treating cancer
12/16/1998EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0883695A1 Method and composition for hair removal
12/16/1998EP0883625A1 Novel platelet activation protein
12/16/1998EP0883404A1 Combination therapy for osteoporosis
12/16/1998EP0883403A1 Method for treating sexual dysfunctions
12/16/1998EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998EP0883398A1 Method of inhibiting photoaging of skin
12/16/1998CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix
12/16/1998CN1202111A Use of epinastine in the treatment of pain
12/15/1998US5849899 Human tumor suppressor
12/15/1998US5849803 Method of treating erectile dysfunction with nitroglycerine
12/15/1998US5849793 HIV matrix protein tyrosine position 29 pocket binders
12/15/1998US5849774 Treatment of sepsis-induced acute renal failure
12/15/1998US5849761 Peripherally active anti-hyperalgesic opiates
12/15/1998US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849706 Method of treating retained asthma pulmonary secretions
12/15/1998US5849587 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
12/15/1998US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998US5849556 Human growth-related CDC10 homolog
12/15/1998US5849312 Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin
12/15/1998CA2163534C Inhibition of hair growth
12/15/1998CA2144513C Morphogen-induced periodontal tissue regeneration
12/15/1998CA1340241C Method for marking solvent dilution microcarriers
12/15/1998CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface
12/13/1998CA2234424A1 Novel compounds
12/11/1998CA2233584A1 7tm receptor hlwar77
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998WO1998055624A1 Bacterial pheromones and uses therefor
12/10/1998WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998WO1998055453A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055139A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055112A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998WO1998055110A2 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
12/10/1998WO1998055103A1 Anti-tumoral therapy agent
12/10/1998WO1998055091A1 Pyrrolidine derivative hair growth compositions and uses
12/10/1998WO1998055090A1 Hair growth compositions and uses
12/10/1998WO1998054966A1 A method of treating cancer
12/10/1998DE19724796A1 Mittel zur Antitumortherapie Means for antitumor therapy
12/10/1998CA2293504A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292699A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998CA2292478A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998CA2292471A1 A method of treating cancer
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2262463A1 New uses for compounds which reduce c-jun gene expression
1 ... 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 ... 1151